Vistagen (VTGN): My opinion

VTGNThis isn't financial advice (hell no). I like this stock. The company has potential. This is a nice buying opportunity in non-expert opinion. So, I'm scooping up before their phase 3 trials.
Beyond Technical AnalysisbiopharmabiopharmaceuticalbiotechbiotechnologyElliott WavepharmaceuticalsvistagenVTGN

Related publications

Disclaimer